Solving the mysteries of bioscience
Foundational Science Fuels Breakthroughs
Inspiring Next-Generation Scientists
The Paul G. Allen Frontiers Group and the American Heart Association/American Stroke Association announced today a new research initiative to support studies on age-related cognitive impairment, including Alzheimer’s disease.
05.10.2018
1 min read
Share:
The Paul G. Allen Frontiers Group and the American Heart Association/American Stroke Association announced today a new research initiative to support studies on age-related cognitive impairment, including Alzheimer’s disease. The two organizations along with additional partners, including the Oskar Fischer Project, are committing $43 million over eight years to fund one or more teams of investigators pursuing brain health and cognitive impairment science.
The request for applications opens today and applications are due by July 6, 2018. The initiative seeks to identify and fund highly-promising teams of researchers pursuing creative, transformative ideas to move brain health and cognitive impairment science forward with greater speed.
More than 5.7 million Americans currently live with Alzheimer’s disease, one of the most common forms of dementia. To date, research has identified many of the symptoms and manifestations of this disease but not the underlying causes that could lead to prevention or treatment.
“Alzheimer’s, dementia and other cognitive ailments have become an enormous emotional and economic burden for our society,” said Tom Skalak, Ph.D., Executive Director of The Paul G. Allen Frontiers Group. “This new American Heart Association-Allen initiative will create new bridges and collaborations between researchers and physicians, ultimately leading to better understanding and treatment of these cognitive disorders.”
The joint initiative aims to bridge an historical divide in the scientific and medical communities between cognition and vascular research.
“Bridging vascular and brain science through innovative research will help scientists shed new light on the causes or contributors to cognitive impairment and dementia,” said Nancy Brown, CEO of the American Heart Association.
Learn more in the press release.
The Paul G. Allen Frontiers Group, a division of the Allen Institute, is dedicated to exploring the landscape of bioscience to identify and foster ideas that will change the world. The Frontiers Group recommends funding to the Paul G. Allen Family Foundation, which then invests through award mechanisms to accelerate our understanding of biology, including: Allen Discovery Centers at partner institutions for leadership-driven, compass-guided research; and Allen Distinguished Investigators for frontier explorations with exceptional creativity and potential impact. The Paul G. Allen Frontiers Group was founded in 2016 by the late philanthropist and visionary Paul G. Allen. For more information, visit alleninstitute.org/division/frontiers-group/
09.11.2024
09.10.2024